SCARB1 and atherosclerosis: On the other hand, SRB-1 overexpression in the liver reduces serum HDL levels and reduces the risk of atherosclerosis, suggesting that SRB-1 overexpression in the liver may promote cholesterol efflux through reverse cholesterol pathways [13].